Human IL-7 ELISA Kit

Contact us
Diaclone
Product Code: 850.040.192
Product Group: ELISA Kits
Supplier: Diaclone
CodeSizePrice
850.040.1922 x 96 (pre-coated)£570.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Human
Regulatory Status: RUO

Further Information

Assay Range:
6.25-200 pg/ml
Cross reaction:
No cross reactivity with other human cytokines
Description:
Diaclone ELISA Kits include pre-coated strip plates biotinylated secondary antibody standards controls (where applicable) buffers streptavidin-HRP TMB stop reagents and a detailed procedure.
Detection Target:
IL-7
Incubation:
2h45
Reactivity:
Human
Research Area:
Cytokines / Growth Factors
Sample Size:
100 µl
Sample Types:
Serum Plasma Cell culture supernatant
Sensitivity:
3 pg/ml
Specificity:
Recognizes both natural and recombinant human IL-7

References

  1. Bikker A. et al. Arthritis Rheum.2010; 62(4): 969-77. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjogren's syndrome correlates with increased inflammation. https://www.ncbi.nlm.nih.gov/pubmed/20131250
  2. Butler M. O. et al. PLoS One2012; 7(1): e30229. Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help.. https://www.ncbi.nlm.nih.gov/pubmed/22279573
  3. Churchman S. M. and F. Ponchel Rheumatology 2008;47: 753-759. Interleukin-7 in rheumatoid arthritis. https://www.ncbi.nlm.nih.gov/pubmed/18356170
  4. Kang I. et al. J. Imunol. 2004; 173(1): 673 - 681. Age-Associated Change in the Frequency of Memory CD4+ T Cells. Impairs Long Term CD4+ T Cell Responses to Influenza Vaccine. https://www.ncbi.nlm.nih.gov/pubmed/15210831
  5. Levy Y. et al.J Clin Invest.2009?; 119(4): 997-1007. Enhanced T cell recovery in HIV-1?infectedadults through IL-7 treatment. https://www.ncbi.nlm.nih.gov/pubmed/19287090
  6. Perales M-A. et al. Blood2012;120:4882-4891. Recombinant human interleukin-7 (CYT107) promotes T-cell recovery after allogeneic stem cell transplantation. https://www.ncbi.nlm.nih.gov/pubmed/23012326
  7. Plana M. et al.Immunology2011; 133(3): 318-2. The reconstitution of the thymus in immunosuppressed individuals restores CD4-specific cellular and humoral immune responses.. https://www.ncbi.nlm.nih.gov/pubmed/21501161
  8. Sereti I. et al. Blood2009;113(25): 6304-6314.. IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. https://www.ncbi.nlm.nih.gov/pubmed/19380868
  9. Sportes C.et al.Clin. Cancer Res.2010;16(2): 727-735. Phase I Study of Recombinant Human Interleukin-7 Administration in Subjects with Refractory Malignancy. https://www.ncbi.nlm.nih.gov/pubmed/20068111
  10. Thiebaut R. et al.Clinical Infectious Diseases2016;62(9): 1178-1185. Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies.. https://www.ncbi.nlm.nih.gov/pubmed/26908786
  11. van Roon J. A. et al. Ann Rheum Dis.2003; 62(2): 113-9.. Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis. https://www.ncbi.nlm.nih.gov/pubmed/12525379
  12. van Roon J. A. et al. Ann Rheum Dis.2007; 66(5): 664-9.. Persistence of interleukin 7 activity and levels on tumour necrosis factor alpha blockade in patients with rheumatoid arthritis. https://www.ncbi.nlm.nih.gov/pubmed/17185327